These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26463732)

  • 1. Dysregulated FGF signalling in neoplastic disorders.
    Tanner Y; Grose RP
    Semin Cell Dev Biol; 2016 May; 53():126-35. PubMed ID: 26463732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
    Flippot R; Kone M; Magné N; Vignot S
    Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor signalling: from development to cancer.
    Turner N; Grose R
    Nat Rev Cancer; 2010 Feb; 10(2):116-29. PubMed ID: 20094046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of FGFR-mediated carcinogenesis.
    Ahmad I; Iwata T; Leung HY
    Biochim Biophys Acta; 2012 Apr; 1823(4):850-60. PubMed ID: 22273505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.
    Carter EP; Fearon AE; Grose RP
    Trends Cell Biol; 2015 Apr; 25(4):221-33. PubMed ID: 25467007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR signalling in women's cancers.
    Fearon AE; Gould CR; Grose RP
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
    Brooks AN; Kilgour E; Smith PD
    Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
    Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
    J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and challenges in targeting FGFR signalling in cancer.
    Babina IS; Turner NC
    Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering role of FGFR signalling pathway in pancreatic cancer.
    Kang X; Lin Z; Xu M; Pan J; Wang ZW
    Cell Prolif; 2019 May; 52(3):e12605. PubMed ID: 30945363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-regulated FGF receptors as therapeutic targets in cancer.
    Knights V; Cook SJ
    Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics.
    Parish A; Schwaederle M; Daniels G; Piccioni D; Fanta P; Schwab R; Shimabukuro K; Parker BA; Helsten T; Kurzrock R
    Cell Cycle; 2015; 14(13):2121-8. PubMed ID: 25950492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network.
    Xu R; Rudd TR; Hughes AJ; Siligardi G; Fernig DG; Yates EA
    FEBS J; 2013 May; 280(10):2260-70. PubMed ID: 23441759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered FGF signalling in congenital craniofacial and skeletal disorders.
    Moosa S; Wollnik B
    Semin Cell Dev Biol; 2016 May; 53():115-25. PubMed ID: 26686047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
    Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future applications of FGF/FGFR inhibitors in cancer.
    Ghedini GC; Ronca R; Presta M; Giacomini A
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.